What Is Vitamin B12? Normal vs Optimal Range Explained
Want to check YOUR levels? Upload labs freeFree, 10 seconds →
Normal vs Optimal Range
Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.
| Range Type | Low | High | Unit |
|---|---|---|---|
| Lab Normal | 200 | 900 | pg/mL |
| Optimal | 500 | 800 | pg/mL |
Why Optimal Matters
Most labs flag vitamin B12 as deficient only below 200 pg/mL, but this threshold was set to catch pernicious anemia—the most severe form of deficiency—not to protect neurological function. Nerve damage from inadequate B12 begins at levels well above 200 pg/mL. The CTD maps over 580 chemical-gene interactions involving cobalamin metabolism genes (MTR, MTRR, TCN2, MMACHC), illustrating how many metabolic pathways depend on adequate B12 for proper function. Japan and several European countries recognized this problem decades ago by setting their lower reference limit at 500 pg/mL rather than 200. Patients with B12 levels in the 200–400 pg/mL range routinely present with fatigue, tingling in the hands and feet, brain fog, and depression—symptoms that resolve when supplementation pushes their levels above 500. The 200 pg/mL cutoff misses these people entirely.
PubMed indexes over 38,000 publications on vitamin B12 and cobalamin, making it one of the most researched micronutrients in clinical medicine. González-Ludlow et al. (2025, Nutrients) demonstrated that maternal B12 concentrations during pregnancy directly influence neonatal nutritional status and adiposity, highlighting that B12's impact extends beyond nerve function to metabolic programming. PharmGKB documents pharmacogenomic interactions between B12 metabolism and common medications, particularly metformin—the world's most prescribed diabetes drug, which causes B12 deficiency in 10–30 percent of long-term users by blocking calcium-dependent absorption of the B12-intrinsic factor complex. FAERS reports over 8,500 adverse events mentioning B12 deficiency as a complication of medication use, with PPIs and metformin accounting for the majority.
The methylation cycle that converts homocysteine to methionine requires B12 as an essential cofactor. When B12 drops below 500 pg/mL, this conversion slows, allowing homocysteine to accumulate—a recognized independent risk factor for cardiovascular disease, stroke, and cognitive decline. Methylmalonic acid (MMA) also rises when B12 is insufficient, because B12 serves as the cofactor for the enzyme that converts methylmalonyl-CoA to succinyl-CoA in the mitochondria. Elevated MMA causes fatigue at the cellular level by disrupting energy production in every cell. The critical insight is that serum B12 measures total circulating cobalamin, including inactive analogs, so a serum level of 350 pg/mL may represent functional deficiency if most of that B12 is bound in inactive forms. This is why MMA and homocysteine are confirmatory tests that should accompany borderline B12 results.
“Maternal folate and vitamin B12 concentrations during pregnancy influence neonatal nutritional status and adiposity, demonstrating that B12 adequacy during critical windows affects metabolic programming beyond the nervous system.”— González-Ludlow et al., Nutrients (2025)
Want to see where YOUR levels fall?
Upload labs free — instant results →Symptoms When Low
Symptoms When High
What Affects This Marker
Medications That Lower It
Medications That Raise It
FAQ
References
- [1]González-Ludlow I, et al. Maternal Folate and Vitamin B12 Concentrations During Pregnancy Influence Neonatal Nutritional Status and Adiposity. Nutrients. 2025. PMID: 39940230
- [2]Comparative Toxicogenomics Database (CTD): 580+ chemical-gene interactions involving cobalamin metabolism genes (MTR, MTRR, TCN2, MMACHC)
- [3]FDA Adverse Event Reporting System (FAERS): 8,500+ adverse events mentioning B12 deficiency as a medication complication, predominantly PPI and metformin classes
- [4]PharmGKB: pharmacogenomic annotations for B12 metabolism and metformin interaction pathways
- [5]PubMed: 38,000+ indexed publications on vitamin B12, cobalamin metabolism, and deficiency-related neurological disease
- [6]Green R, et al. Vitamin B12 deficiency. Nature Reviews Disease Primers. 2017;3:17040
- [7]Chapman LE, et al. Association between metformin and vitamin B12 deficiency: systematic review and meta-analysis. Diabetes & Metabolism. 2016;42(5):316-327
Check your medications
Check Free →